EmergingMed
EmergingMed operates a web-based clinical trial navigation and matching platform that helps patients find relevant trials via structured profile questionnaires and staff-assisted Clinical Trial Navigators, and distributes the service through partner websites and applications. The company is a Carebox Healthcare Solutions subsidiary based in Durham, NC.
- Company typePrivate
- Founded2000
- HeadquartersDurham, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What EmergingMed does
EmergingMed is a Durham, North Carolina-based clinical trial navigation and matching service that helps patients find and connect with potentially relevant clinical trials based on structured health profile questionnaires. The web-based platform is organized around three core components: a "View Trials" browsing interface, a "Match to Trials" feature driven by patient-completed Patient Profiles, and a staff-assisted "Clinical Trial Navigators" service that provides personalized guidance and, with patient consent, shares referral information directly with clinical trial sites. The product is delivered through the primary app.emergingmed.com domain and is also embedded in partner websites and mobile applications, extending reach to patients already engaged with health-related platforms. The technical foundation consists of a web-based patient profile and questionnaire system, a clinical trial matching algorithm, a human navigator channel, and secure hosting infrastructure located near Chicago, Illinois, with encryption for third-party data transmissions.
The service is offered free to patients, indicating a non-consumer monetization model — likely referral fees, sponsor relationships, or site-side billing — though no pricing, contracts, or revenue figures are publicly disclosed. EmergingMed operates as Final Four Health Solutions, LLC, a wholly owned subsidiary of Carebox Healthcare Solutions, Inc., positioning it within a broader healthcare technology group. The company maintains GDPR, EU-U.S. Privacy Shield, and Swiss-U.S. Privacy Shield compliance as a Data Controller, enabling cross-border processing of EU and Swiss subject data. Headcount is in the 11–50 range, consistent with a small, operationally focused organization rather than a scaling enterprise. The company has been continuously operating since founding in 2000, with a single recorded funding round from Advantage Capital in 2005.
EmergingMed firmographics
Firmographics- Name
- EmergingMed
- Legal name
- EmergingMed
- Website
- https://app.emergingmed.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EmergingMed operates a web-based clinical trial navigation and matching platform that helps patients find relevant trials via structured profile questionnaires and staff-assisted Clinical Trial Navigators, and distributes the service through partner websites and applications. The company is a Carebox Healthcare Solutions subsidiary based in Durham, NC.
- Ownership category
- akta.pro rank
EmergingMed industry classification
Industry- Product category
- Clinical Trial Patient Recruitment / Matching
- NAICS
- Other Ambulatory Health Care Services (6219)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)
- akta.pro secondary industry
- Site Identification & Feasibility (HLAGACAB)
Keywords
Where EmergingMed is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
EmergingMed business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Distribution channels4 records
Marketing channels3 records
EmergingMed product offering
Product offeringCore offering
EmergingMed operates a web-based clinical trial matching and referral platform that helps patients identify and connect with relevant clinical trials based on structured Patient Profile questionnaire responses. The service combines a self-serve search/match experience with staff-assisted Clinical Trial Navigator support and is delivered through the company's website and partner platforms. Patients access the service free of charge, with optional consent-based sharing of referral data to clinical trial sites.
Product overview
EmergingMed offers a unified clinical trial navigation platform consisting of multiple integrated components: the core Clinical Trial Navigation Service enables patients to View Trials and Match to Trials based on health profiles. The Patient Profiles feature collects questionnaire responses to facilitate personalized matching. Clinical Trial Navigators provide staff-assisted support, while the Request a Contact feature enables direct communication between patients and navigators or trial sites.
Differentiator
Problem solved
Functional benefit
Products and services
- EmergingMed Clinical Trial Navigation Service
Companies that use EmergingMed
Customer profileSegments1 record
Ideal customer profiles2 records
EmergingMed technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
EmergingMed partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
EmergingMed competitors and assessment
Company assessmentDirect peers
- Antidote (formerly TrialReach): Antidote operates a digital patient recruitment platform that matches patients to clinical trials via structured questionnaires and condition-specific landing pages. It directly competes with EmergingMed across patient-side matching and sponsor-side recruitment services.
- SubjectWell: SubjectWell recruits patients for clinical trials via a network of online patient communities and a concierge service. It competes with EmergingMed on patient acquisition and matched referrals for sponsor trials.
- BBK Worldwide: BBK Worldwide is a long-established patient recruitment and engagement firm for clinical trials, offering both digital and human-supported matching. It overlaps with EmergingMed's Clinical Trial Navigator service and sponsor-facing recruitment work.
- Power (formerly Patient Alliance): Power provides centralized clinical trial patient recruitment services, including site-based and community-based enrollment support for pharma and CRO sponsors. It is comparable to EmergingMed's navigator and site-referral distribution channels.
- Deep 6 AI: Deep 6 AI uses AI and NLP to mine EHR data for patient-trial matching, selling to providers and sponsors. It is a direct competitor to EmergingMed's patient matching proposition, with more advanced AI/clinical-data capabilities.
Emerging players
- Massive Bio: Massive Bio provides AI-driven oncology patient matching and clinical trial enrollment services to pharma sponsors. It overlaps with EmergingMed's trial matching functionality but with a narrower oncology focus.
- Clara Health: Clara Health is a patient-facing platform that assists individuals in finding and enrolling in clinical trials. It overlaps with EmergingMed's matching and navigator offering with a stronger direct-to-consumer approach.
- XpertDox: XpertDox runs AI-enabled clinical trial matching and rare disease databases. It is comparable to EmergingMed's matching algorithm and patient profiles but with an emphasis on rare and genetic conditions.
Broad incumbents
- IQVIA: IQVIA is one of the largest global CROs and offers patient recruitment, site identification, and real-world data products as part of its broad clinical operations portfolio. It competes with EmergingMed in sponsor recruitment, but as a diversified mega-vendor rather than a niche specialist.
Others
- ClinicalTrials.gov (NIH/NLM): ClinicalTrials.gov is the public registry of clinical trials operated by the U.S. National Library of Medicine. While not a commercial competitor, it is the underlying data source and consumer-facing search entry point that EmergingMed's matching builds on top of, making it an adjacent ecosystem participant.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
EmergingMed social profiles
Digital presenceEmergingMed compliance and trust
Trust signalCompliance3 records
EmergingMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
EmergingMed leadership team
Management profileNumber of profiles
Profiles1 record
EmergingMed funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EmergingMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EmergingMed
What does EmergingMed do?
EmergingMed operates a web-based clinical trial matching and referral platform that helps patients identify and connect with relevant clinical trials based on structured Patient Profile questionnaire responses. The service combines a self-serve search/match experience with staff-assisted Clinical Trial Navigator support and is delivered through the company's website and partner platforms. Patients access the service free of charge, with optional consent-based sharing of referral data to clinical trial sites.
Is EmergingMed a public or private company?
EmergingMed is a private company. It is classified as corporate owned and is currently operating.
When was EmergingMed founded?
EmergingMed was founded in 2000. It employs 11 to 50 people.
Where is EmergingMed based?
EmergingMed is headquartered in Durham, United States, in the North America region.
Who are EmergingMed's main competitors?
Direct peers on record are Antidote (formerly TrialReach), SubjectWell, BBK Worldwide, Power (formerly Patient Alliance) and Deep 6 AI. Emerging players are Massive Bio, Clara Health and XpertDox. IQVIA is listed as a broad incumbent. ClinicalTrials.gov (NIH/NLM) is listed as an others.
Does EmergingMed have an API?
No public API is recorded for EmergingMed.
What industry is EmergingMed in?
EmergingMed's product category is Clinical Trial Patient Recruitment / Matching. Its primary akta.pro industry code is HLAAANAI, Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials), with a secondary code of HLAGACAB, Site Identification & Feasibility. Its NAICS code is 6219 and its SIC code is 8090.